Skip to main content
Premium Trial:

Request an Annual Quote

Ovation Closes $1.9M Seed Round, Inks Commercial Partnership

NEW YORK (360Dx) – Ovation said today that it has raised nearly $1.9 million through an expanded round of seed financing, initially led by StageDotO and Longfellow Ventures.

The company — which offers a lab service for the tracking of samples, workflows, and processes, and a research service for facilitating collaboration and data sharing between separate teams — also announced that it has partnered with health information services provider The Hunt Group to offer a commercialization platform for diagnostic laboratories.

Under the terms of the deal, Ovation will integrate its offerings with The Hunt Group's billing consultation services to provide customers with a seamless exchange of billing data and help streamline the reimbursement process. Additional terms of the partnership were not disclosed.

"We have shown that we can help diagnostic labs scale quickly by providing a platform that works across every element of a lab's operations," Ovation CEO Barry Wark said in a statement. "By continuing to add best-in-class partners in critical functional areas and drawing innovation from our expanding support network of industry experts, Ovation is helping our customers to change the role of the diagnostic lab in clinical trials and the demonstration of real world evidence."

Ovation also said today that John Walker, head of core data and analytics at the Novartis Institutes for Biomedical Research, has joined its board of directors. Additionally, the company has expanded its advisory panel to include Adaptive Biotechnologies President and CEO Chad Robins, Telematica CEO and Managing Director Rich Miller, and Maxwell Health Cofounder Vinay Gidwaney.